** Medical equipment maker Thermo Fisher's shares TMO.N rise 2.2% to $444.39 premarket
** TMO posts Q1 adj. profit of $5.15 per share, beating analysts' estimates of $5.10 per share, according to data compiled by LSEG
** Company reports Q1 revenue of $10.36 billion vs estimates of $10.23 billion
** Sales at the company's laboratory products segment, which makes up more than half of its total sales, came in at $5.64 billion vs estimate of $5.65 billion
** As of last close, TMO has fallen 16.4% YTD
(Reporting by Siddhi Mahatole)
((siddhi.mahatole@thomsonreuters.com))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。